123 related articles for article (PubMed ID: 4004989)
1. Fibrinolysis and plasminogen concentration in aortic intima in relation to death following myocardial infarction.
Smith EB; Ashall C
Atherosclerosis; 1985 May; 55(2):171-86. PubMed ID: 4004989
[TBL] [Abstract][Full Text] [Related]
2. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
Smith EB; Crosbie L
Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
[TBL] [Abstract][Full Text] [Related]
3. The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions.
Smith EB; Crosbie L; Cochran S
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):495-8. PubMed ID: 2151935
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.
Smith EB; Keen GA; Grant A
Atherosclerosis; 1990 Oct; 84(2-3):165-71. PubMed ID: 2149267
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic factors in human aortic intima.
Smith EB; Staples EM
Lancet; 1981 May; 1(8231):1171-4. PubMed ID: 6112525
[TBL] [Abstract][Full Text] [Related]
6. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
8. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.
Henareh L; Jogestrand T; Agewall S
Thromb Res; 2009 Nov; 124(5):526-30. PubMed ID: 19427679
[TBL] [Abstract][Full Text] [Related]
10. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
Eisenberg PR; Sherman LA; Tiefenbrunn AJ; Ludbrook PA; Sobel BE; Jaffe AS
Thromb Haemost; 1987 Feb; 57(1):35-40. PubMed ID: 3109058
[TBL] [Abstract][Full Text] [Related]
11. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
Ishida T; Tanaka K
Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen, fibrin and the arterial wall.
Smith EB
Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in patients with acute tonsillitis.
Kosugi T; Hamaya M; Matsuo O; Mihara H
Ann Otol Rhinol Laryngol; 1979; 88(3 Pt 1):366-7. PubMed ID: 464529
[TBL] [Abstract][Full Text] [Related]
15. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
16. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
Francis CW; Connaghan DG; Marder VJ
Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease.
Martin-Paredero V; Vadillo J; Diaz J; Espinosa A; Berga C; Segura J; Sanchez J; Barbod A; Villaverde C; Richard CM
Cardiovasc Surg; 1998 Oct; 6(5):457-62. PubMed ID: 9794264
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen/fibrin in atherogenesis.
Smith EB; Thompson WD; Crosbie L; Stirk CM
Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
20. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
